Cuts will slow Japan's vascular access market
This article was originally published in Clinica
Executive Summary
Japan's rapidly ageing population (by 2015, more than one-quarter of the nation will be considered "elderly") will lead to an increase in infusion therapies, such as vascular access (VA) procedures, to treat cancer and end-stage renal disease. So says a report by Canadian healthcare research firm, Millennium Research Group.